Skip to content

Usage of Multiple Drugs in Treatment of Postoperative Vomiting After Laparoscopic Appendectomy

Comparative Study Between Ondansetron, Isopropyl Alcohol Inhalation and Super Hydration in Treatment of Postoperative Emesis After Laparoscopic Appendectomy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04403191
Enrollment
240
Registered
2020-05-27
Start date
2019-03-10
Completion date
2020-02-10
Last updated
2020-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

to Treat the Vomiting Frequently Occur Post-laparoscopic by Different Anti Emetic Drugs

Brief summary

To compare and evaluate the antiemetic effect and the safety of ondansetron, inhalational isopropyl alcohol and super hydration on adult patients after laparoscopic appendectomy.

Detailed description

This prospective double-blind study done on 240 patients admitted to surgical I.C.U after laparoscopic appendectomy. Those who had preoperative Koivuranta vomiting score of more than 3 enrolled in our study. Every group contains 80 patients. Patients of group A received ondansetron 4 mg intravenous immediately once reached to I.C.U and another same dose after 6 hours while patients of group B received isopropyl alcohol 70% inhalation every 15 min for 4 times then repeated after 6 hours. The last group C received intravenous normal saline at rate of 20 ml/kg over 30 minute and repeated by the same dose after 6 hours. The duration of the study was 24 hours post-operatively. As PONV is self-limited within 24 hours.

Interventions

DRUGOndansetron

ondansetron 4 mg intravenous immediately once reached to I.C.U and another same dose after 6 hours while patients of group

DRUGisopropyl alcohol 70% inhalation

inhalation every 15 min for 4 times then repeated after 6 hours

PROCEDURElaparoscopic appendectomy

all patients received post operatively after laparoscopic appenectomy

Sponsors

King Abdul Aziz Specialist Hospital
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

postoperative nausea and vomiting

Exclusion criteria

systemic disease as diabetes or hypertension local gastric diseases

Design outcomes

Primary

MeasureTime frameDescription
numbers of vomiting attacksfor one daynumbers of vomiting attacks recorded every 15 minutes for one day

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026